BTL's EMFACE Reaches 1 Million Treatment Milestone
The EMFACE treatment has achieved an impressive milestone by becoming the fastest-growing non-invasive facial lifting procedure, having surpassed 1 million treatments globally in under two years. This remarkable accomplishment positions EMFACE at the forefront of non-invasive facial procedures, designed meticulously to improve both skin texture and the overall muscle tone beneath, offering patients a more youthful and lifted appearance.
Innovative Technology Behind EMFACE
Developed by BTL, a pioneer in medical technology, EMFACE has revolutionized cosmetic treatments since its launch. Unlike traditional procedures that rely on injections or invasive measures, EMFACE employs an operator-independent technique that targets facial muscles directly, while enhancing skin quality simultaneously.
Expert Insights on EMFACE
According to Dr. Yael Halaas, a respected facial plastic surgeon, "The ability to stimulate elevator muscles allows us to lift facial features from within—something that was never possible before with injectables or traditional energy-based devices." This innovative approach minimizes discomfort and eliminates the need for needles or significant downtime, making it an appealing choice for both practitioners and patients.
Continued Expansion and Adoption
Throughout the last year, EMFACE has introduced specialized applicators for targeted areas such as the submental region and under the eyes, enhancing its versatility. These new applicators received positive feedback from medical professionals during their presentation at the IMCAS World Congress, marking a significant step in EMFACE's evolution.
Global Recognition and Momentum
The surge in the adoption of EMFACE reflects its effectiveness and growing reputation within the aesthetic community. By integrating EMFACE with traditional injectables, practitioners can now offer patients a comprehensive facial rejuvenation plan that delivers exceptional results without the invasive procedures typically associated with cosmetic enhancements.
"Reaching the impressive milestone of 1 million treatments in merely two years highlights EMFACE's innovative technology and the immense value it provides to medical practitioners and patients alike," stated Tomas Schwarz, CEO of BTL. He emphasized the company's commitment to further develop this groundbreaking platform and to enhance non-invasive facial treatment options as technology continues to advance.
About BTL
Founded in 1993, BTL has risen to prominence as a leading manufacturer of medical equipment, employing over 3,000 individuals, including more than 500 engineers situated across more than 80 countries. The company specializes in offering advanced non-invasive solutions for body shaping, skin tightening, and a variety of aesthetic medical treatments, encompassing intimate health and mental wellness. Some of its noteworthy products include EMSCULPT NEO, EMFACE, EXION, and EMSELLA, alongside proprietary procedures like HIFEM, HIFES, and EXOTMS. For further information, visit www.btlaesthetics.com.
Frequently Asked Questions
What is EMFACE?
EMFACE is a non-invasive facial treatment designed to lift and rejuvenate the skin by targeting facial muscles and improving skin quality.
How many treatments has EMFACE completed?
EMFACE has surpassed 1 million treatments worldwide since its introduction.
What makes EMFACE different from other treatments?
EMFACE is unique for its operator-independent approach that combines muscle stimulation and skin enhancement without the use of needles.
Is there downtime after an EMFACE treatment?
No, one of the advantages of EMFACE is that it requires no downtime, allowing patients to return to their daily activities immediately after treatment.
Who developed EMFACE?
EMFACE was developed by BTL, a leading medical technology company that specializes in non-invasive aesthetic solutions.
